FDA Approves ADMA’s Asceniv for Immune DeficiencyApprovals, Bacterial Infections, FDA/Regulatory, Genetic Diseases, Immune System, Immunoglobulins, Journal of Clinical Immunology, Primary Humoral Immunodeficiency Disease (PIDD or PI), Serious Bacterial Infections (SBI)The U.S. Food and Drug Administration approved ADMA Biologics’ Asceniv to treat primary humoral immunodeficiency disease (PIDD or PI) in adults and adolescents. Read more April 2, 2019/by BioSpace https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png 0 0 BioSpace https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png BioSpace2019-04-02 12:21:502019-04-02 13:12:53FDA Approves ADMA’s Asceniv for Immune Deficiency